Titan Pharmaceuticals CEO Dato' Seow Gim Shen resigns; search for replacement launched

TITAN PHARMACEUTICALS INC

CEO and Chairman Dato' Seow Gim Shen resigned on October 24, 2024 for personal reasons, no disagreement with board or management.
Company has commenced a search for a new CEO; resignation not expected to impact pending business combination with KE Sdn. Bhd.
Resignation effective immediately; Brynner Chiam signed the 8-K as a Board member.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Dato' Seow Gim Shen

Chief Executive Officer and Chairman of the Board

TITAN PHARMACEUTICALS INC

Effective: 2024-10-24
Filed: October 24, 2024, 7:59 PM ET

On October 24, 2024, Dato’ Seow Gim Shen notified the Board of Directors of Titan Pharmaceuticals, Inc. (the “Company”) of his decision to resign as Chief Executive Officer and Chairman of the Board of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dato' Seow Gim Shen resigned as Chief Executive Officer and Chairman of the Board at TITAN PHARMACEUTICALS INC.

Action: resigned
Role: Chief Executive Officer and Chairman of the Board

Exact text from the filing

On October 24, 2024, Dato’ Seow Gim Shen notified the Board of Directors of Titan Pharmaceuticals, Inc. (the “Company”) of his decision to resign as Chief Executive Officer and Chairman of the Board of the Company.

View on SEC.gov

Source: SEC EDGAR

accession 0001829126-24-006949

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.